Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.60 |
| ▸ | MEN1 | O00255 | 2/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.52 |
| ▸ | THRB | P10828 | 1/20 | 0.52 |
| ▸ | HTT | P42858 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | TSHR | P16473 | 2/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.48 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.46 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | USP2 | O75604 | 1/20 | 0.40 |
| ▸ | ACHE | P22303 | 6/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7604787 | 1.00 | ALDH1A1 (0.60) | ALDH1A1MEN1KMT2ATHRBHTT | |
| SCHEMBL11942791 | 1.00 | ALDH1A1 (0.60) | ALDH1A1MEN1KMT2ATHRBHTT | |
| SCHEMBL10941216 | 1.00 | ALDH1A1 (0.60) | ALDH1A1MEN1KMT2ATHRBHTT | |
| SCHEMBL4326524 | 1.00 | ALDH1A1 (0.60) | ALDH1A1MEN1KMT2ATHRBHTT | |
| SCHEMBL10936372 | 1.00 | ALDH1A1 (0.60) | ALDH1A1MEN1KMT2ATHRBHTT | |
| SCHEMBL4335363 | 1.00 | ALDH1A1 (0.60) | ALDH1A1MEN1KMT2ATHRBHTT | |
| SCHEMBL10941081 | 1.00 | ALDH1A1 (0.60) | ALDH1A1MEN1KMT2ATHRBHTT | |
| SCHEMBL427388 | 1.00 | — | — | |
| SCHEMBL9085134 | 1.00 | ALDH1A1 (0.60) | ALDH1A1MEN1KMT2ATHRBHTT | |
| SCHEMBL4301318 | 1.00 | ALDH1A1 (0.60) | ALDH1A1MEN1KMT2ATHRBHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 678 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8461135-B2 | Boron-containing small molecules as anti-inflammatory agents | ANACOR PHARMACEUTICALS, INC. (US) | 2013-06-11 | — | — | US | claimed |
| US-8304378-B2 | Cleaning and disinfectant compositions | DIVERSEY, INC. (US) | 2012-11-06 | — | — | US | claimed |
| US-8039450-B2 | Boron-containing small molecules as anti-inflammatory agents | ANACOR PHARMACEUTICALS, INC. (US) | 2011-10-18 | — | — | US | claimed |
| WO-2006052369-A1 | CLEANING AND DISINFECTANT COMPOSITIONS | VIROX TECHNOLOGIES INC. (CA) | 2006-05-18 | — | — | WO | claimed |
| US-20060100122-A1 | Cleaning and disinfectant compositions | THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., AS NOTES COLLATERAL AGENT | 2006-05-11 | — | — | US | claimed |
| EP-0666847-B1 | TRYPTAMINE ANALOGS WITH 5-HT1D SELECTIVITY | ALLELIX BIOPHARMA (CA) | 1998-06-17 | — | — | EP | claimed |
| US-5496957-A | 5-HYDOXYTRYPTAMINE | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 1996-03-05 | — | — | US | claimed |
| EP-0666847-A1 | TRYPTAMINE ANALOGS WITH 5-HT1D SELECTIVITY | Allelix Biopharmaceuticals Inc. (CA) | 1995-08-16 | — | — | EP | claimed |
| WO-1995006638-A1 | TRYPTAMINE ANALOGS WITH 5-HT1D SELECTIVITY | ALLELIX BIOPHARMACEUTICALS INC. (CA) | 1995-03-09 | — | — | WO | claimed |
| US-3948964-A | CYCLIC ETHERS, ETHER ALCOHOLS, CARBOXYLIC ESTERS, KETONES | DYNAMIT NOBEL AKTIENGESELLSCHAFT (DT) | 1976-04-06 | — | — | US | claimed |
| US-12600812-B2 | Dispersants made from isocyanates and amines | HUNTSMAN PETROCHEMICAL LLC | 2026-04-14 | — | — | US | disclosed |
| US-20260085199-A1 | PAINT COMPOSITION | NOURYON CHEMICALS INTERNATIONAL B.V. (NL) | 2026-03-26 | — | — | US | disclosed |
| EP-4715018-A1 | PAINT COMPOSITION | Nouryon Chemicals International B.V. (NL) | 2026-03-25 | — | — | EP | disclosed |
| EP-3872140-B1 | DISPERSANT POLYMER AND COMPOSITION COMPRISING THE SAME | Axalta Coating Systems Gmbh (CH) | 2026-01-28 | — | — | EP | disclosed |
| US-12497480-B2 | — | — | 2025-12-16 | — | — | US | disclosed |
| EP-0054946-A1 | Basic substituted pyridazines, their preparation and their use | CASSELLA Aktiengesellschaft (DE) | 1982-06-30 | — | — | EP | disclosed |
| US-4316810-A | Gelled oil base compositions and methods of preparation and use of same | HALLIBURTON COMPANY (US) | 1982-02-23 | — | — | US | disclosed |
| US-4216314-A | CARDIOSELECTIVE B-ADRENOLYTIC AGENTS, ANTIARRHYTHMIC AGENTS AND HYPOTENSIVE AGENTS | CASSELLA FARBWERKE MAINKUR AKTIENGESELLSCHAFT (DE) | 1980-08-05 | — | — | US | disclosed |
| US-4000258-A | INSECTICIDES, ALCOHOLS, POLYOXYETHYLENE (PROPYLENE) GLYCOL | SANDOZ, INC. (US) | 1976-12-28 | — | — | US | disclosed |
| US-3948964-A | CYCLIC ETHERS, ETHER ALCOHOLS, CARBOXYLIC ESTERS, KETONES | DYNAMIT NOBEL AKTIENGESELLSCHAFT (DT) | 1976-04-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12600812-B2 | Dispersants made from isocyanates and amines | SLC18A1, DRD2, INO80 | ALDH1A1 2279/4885MEN1 3292/4885KMT2A 1238/4885 |
| US-20260085199-A1 | PAINT COMPOSITION | CD44, B4GALT1, CSGALNACT1 | ALDH1A1 255/4885MEN1 4147/4885KMT2A 1418/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.